Provided by Tiger Fintech (Singapore) Pte. Ltd.

Instil Bio, Inc.

35.07
+2.186.63%
Post-market: 35.070.00000.00%18:18 EDT
Volume:408.49K
Turnover:14.47M
Market Cap:230.06M
PE:-2.93
High:37.02
Open:33.31
Low:32.01
Close:32.89
Loading ...
Sep 13, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Major Issues Report

8-K - Current report
Apr 27, 2021

Major Issues Report

8-K - Current report
Apr 20, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 15, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 13, 2021

Major Issues Report

8-K - Current report
Apr 05, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 01, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 01, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Mar 23, 2021

Major Issues Report

8-K - Current report
Mar 18, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 15, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 26, 2021

Correspondence

CORRESP [Cover] - Correspondence